Transcript The Japanese Pharmaceutical Market

Fundamental Data
India は、900millで 2030年には中国の15-29歳の労働人口で追い抜く
Japan
USA
China
India
Population (Million)(05’)
２０１２
(7年間での人口増）
128.1
127.2
(-1.1)
298.2
317.5
(+13.9)
1315.8
1384.7
(+68.9)
1133.4
Area (Mkm2)
0.37
9.63
9.60
3.28
GNI(Billion $)(04’)
47.3
121.6
19.4
6.73
GNI(000$)/capita
37
41
1.5
0.62
Import/Export (Billion $)
1110
2639
2502
211
Doctors/10,000
20.1
54.9
16.4
5.1
1236.6
(+103.2)
1
India’s macroeconomic and demographic outlook will
support strong growth in the healthcare market
Economy is turning around & strong GDP growth in future
Rising disposable income with growing share of healthcare spend
4.1
Healthcare as % of
overall spend
7.7%
8%
6.7%
6%
5.0%
7.2%
7.7%
5.5%
4.5%
4%
2%
Disposable income
( $ ‘000 per annum)
9.3%
13%
2.3
9%
86%
1.4
7%
Others
92%
93%
0%
2010
2011
2012
2013
2014 2015F 2016F 2017F
2005
Rising literacy rate increases healthcare awareness
74
63
1,318
0-14
28.7%
27.3%
15-64
65.9%
66.7%
5.4%
6.0%
2014
2018(F)
65+
2001
2006
2011
Source: CensusIndia, NCEAR, McKinsey, Economist Intelligence Unit, IMS Market Prognosis
2025(F)
1,256
+280 Mn
61
2015
Fastest growing population in the age group over 65 years old
Population
( millions)
India real GDP growth
10%
Age
group
-0.1%
1.5%
3.9%
CAGR
Rural market is one of the fastest growing geographic
segment in Indian Pharmaceutical market (IPM)
Town
split
by value
Townclass
class
split
for
Indian Pharma market
Region
wise
Split
Zone wise split for Indian Pharma market
CAGR
(2011-14)
Rural
Tier II- V
16%
18%
16%
19%
18%
10%
East
18%
27%
West
26%
24%
Tier I
32%
32%
12%
South
~60% of rural
market lies with
South & East
zone
25%
32%
Metros
33%
31%
32%
North
11%
2011
2014
Non Rural
17%
Rural
Note: Different publications
Indian companies dominate IPM, however market is fragmented
with only 40% share with top 10 companies
Chronic-Acute Split
27%
29%
Indian-MNC Split
29%
16%
28%
• 1.5x growth of chronic over
acute therapy
73%
71%
10%
• Domestic players
account for more than 70%
of the market
11%
71%
72%
13%
MNC
Chronic
2011
Acute
2014
2011
OTC vs. Prescription Market
Top Companies by sales (Indian Vs. MNC)
S. No.
~$17 Bn
~12%
Total
IPM ~$12 Bn
~$ 5 Bn
18%- 20%
~$ 3 Bn
• OTC market to grow at 1820% CAGR
OTC Drugs
2011
2014
Indian
2014
Prescription drugs
CAGR
2011 - 14
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
COMPANY
ABBOTT
CIPLA
SUN
RANBAXY
ZYDUS CADILA
GLAXOSMITHKLINE
MANKIND
ALKEM
MACLEODS PHARMA
PFIZER
LUPIN LIMITED
INTAS PHARMA
TORRENT PHARMA
EMCURE
SANOFI
INDIAN (Y/N)
N
Y
Y
N
Y
N
Y
Y
Y
N
Y
Y
Y
Y
N
• 11 of top 15
Pharma
companies are
Indian
Note: Different publications
Indian Pharma industry is expected to show strong
growth supported by positive economic outlook
80
Indian Pharmaceutical Market Growth
Projections
70
Global Rank
USD (billion) .
60
50
40
30
14 of the top 15 global companies are present in
India and are part of the growth story
IMS health market
analysis USD 15-17 bn
20
10
0
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
PWC (High)
McKinsey (Low)
PWC (Base)
McKinsey (High)
Top 15 companies1
Active in India
1
Yes
2
Yes
3
Yes
4
Yes
5
Yes
6
Yes
7
Yes
8
Yes
9
No
Astellas Pharma
Claris Otsuka
Daiichi Sankyo
Eisai
Kyowa Hakko Bio
10
Yes
Meiji Seika Pharma
11
Yes
12
Yes*
13
Yes
14
Yes
15
Yes
Santen
Pharmaceutical
Takeda
Pharmaceuticals
Ajinomoto
OmniChem
Japanese
pharmaceutical
companies in India
Companies
• By 2020, India is expected to be comparable to all developed market other than the US, Japan and China
• In terms of volumes, by 2020, India will be second only to the US
Notes: 1) IMS Sales Audit Database
Gap was declined ,
Still we have a GAP!
so, we need to do
continuous effort
mutually!
（Indian Desire)Focus Shift……
• India Attraction – Shift from API to….
– Contract Manufacturing
– Drug Product Development / Manufacturing
– Custom Research Organizations
– High Absolute Growth of Local Pharma
Market.
7
Confidential -- Reva Proprietary Info.
•
•
•
•
•
•
•
•
•
•
•
•
日本とインドの違い/ Business
cultural difference（J and I)
均一的/ Homogenous
多様性/ Diversity
日本的時間感覚/ Japanese time インド的時間感覚/ Indian time
詳細なる計画/Detailed plan
変化を前提とした計画 / dynamism
日本での成功体験が素/Based on success experience in Japan
勢い/ momentum
ボトムアップ/ Bottom-up
トップダウン/ Top-down
組織主義/ Collectivistic
個人主義/ Individualistic
日本・インド間の意識の違いをまず理解/ First, understand each other
■互いの認識する定義は同じか？「品質」とは？
Like Japanese and Indian have different perception of the word, likeQuality
■互いの国のビジネス文化を理解し、長期的な目線も大切
Understanding each business culture background. Establishing long term
relationship
• インドは今やドッグイヤーではなくラットイヤーで回転している。
• 日本はついていけるか？